Kapadia Sandip 4
4 · Harmony Biosciences Holdings, Inc. · Filed Aug 19, 2025
Insider Transaction Report
Form 4
Kapadia Sandip
CHIEF FINANCIAL OFFICER
Transactions
- Sale
Common Stock
2025-08-15$36.50/sh−21,573$787,378→ 0 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.11 to $36.87. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.